Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
146 Leser
Artikel bewerten:
(0)

Healthcare Market Artificial Intelligence and Advanced Analytics 2017: Medtronic, Roche, and GE Healthcare Are Among the Top Adopters

DUBLIN, November 16, 2017 /PRNewswire/ --

The "Artificial Intelligence and Advanced Analytics in Healthcare" report has been added to Research and Markets' offering.

Research and Markets Logo

The global healthcare industry is in need of solutions that augment providers with insights to make meaningful clinical decisions within less turnaround times, which is critical to demonstrating value of care. Artificial Intelligence has proven its utility in performing data-mining activities on large sets of patient and population health data, addressing vital gaps in automating the clinical workflow. Adoption of artificial intelligence technologies has reduced healthcare costs by 50%, while improving patient outcome by over 50%. Advanced analytic frameworks evaluate 'unstructured data', such as physician-entered notes, health statistics, clinical literature and radiology reports to deliver trends critical to improving the quality of healthcare.

This research service (RS) offers a strategic perspective on the impact of artificial intelligence (AI) and advanced analytics on the global healthcare industry. This RS has been segmented into five chapters, with the first two focusing on analysis of the top trends from both technology and competitive perspectives. the third, fourth and fifth chapters focus on the global adoption landscape, reviewing the roles and strategies of both existing and emerging participants.

Key Questions Answered by this Eesearch Services (RS):

  • What are the major classes of artificial intelligence and advanced analytics technologies? What are the sub-classification of technologies for various clinical applications by commercial attractiveness and intensity of patenting activities?
  • Who are the key stakeholders within the global healthcare industry, including medical device companies, pharmaceutical companies and biotechnology firms that are pioneering technology development initiatives for driving sustainable market growth efforts across potential markets?
  • What is the role of stakeholders across the value chain and their efforts towards development of technologies?
  • How has the global competitive landscape evolved over the past decade, especially with respect to those innovating artificial intelligence solutions for addressing needs faced by the global healthcare industry?

Key Topics Covered:

1. Executive Summary

2. Technology Overview

3. Global Competitive Scenario

4. Global Adoption Landscape

5. Global Technology Value Chain

6. Strategic Recommendations

7. Patent Landscape Assessment

Companies Featured

  • Medtronic
  • Roche
  • GE Healthcare

For more information about this report visit https://www.researchandmarkets.com/research/sfnd4d/artificial

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.